United Kingdom Pet Longevity Market

Overview

The United Kingdom Pet Longevity Market was valued at USD 51.0 million in 2025 and is projected to reach USD 548.2 million by 2034, growing at a CAGR of 30.2% during the forecast period (2026–2034). The market is driven by rising pet ownership, growing demand for preventive healthcare, and increasing spending on pet wellness and longevity solutions. The market covers veterinary longevity clinics, senior-pet care plans, anti-aging drug support services, preventive diagnostics and genetic screening, and palliative and end-of-life care for aging dogs and cats. It differs from broad veterinary services in that its focus is specifically on healthspan and age-related care continuity, rather than general or acute veterinary treatment. The market is shifting from an informal, reactive approach to aging pet care toward structured, recurring senior-pet care programs, as canine longevity drug candidates progress through regulatory review and give veterinary practices and pet owners a clearer signal that lifespan- and healthspan-extension support may become a mainstream clinical service category rather than a niche offering. Regulatory milestones for emerging longevity therapeutics are a central catalyst for this market: progress by biotechnology companies developing canine lifespan-extension drug candidates through the U.S. Food and Drug Administration's conditional approval pathway is creating a new service layer around screening, owner counseling, and monitoring for aging companion animals, even ahead of any such product's commercial availability in the UK specifically. By pet type, senior dogs represented the largest segment of the market in 2025, reflecting the fact that canine longevity drug innovation and geriatric mobility care have so far concentrated first on dogs, while senior cats are also a substantial and growing segment as feline-specific geriatric care awareness increases across UK veterinary practices.

Market Size & Share

Market Dynamics

KEY MARKET TREND

Progress of Canine Longevity Drug Candidates Toward Regulatory Approval Emerging as a Transformational Trend

• Biotechnology companies developing lifespan-extension therapeutics for dogs are advancing through staged regulatory review processes designed specifically for veterinary drug candidates, creating a credible near-term pathway to market that did not exist for this category several years ago.
• Each regulatory milestone a longevity drug candidate clears tends to generate renewed media and veterinary-industry attention, indirectly building public and professional awareness of pet longevity as a distinct clinical care category even before any product reaches commercial availability.
• Veterinary practices are beginning to prepare senior-pet care infrastructure, including recurring wellness plans and diagnostic protocols, in anticipation of eventually incorporating longevity drug screening and monitoring into routine practice offerings.
• Successive, staged regulatory clearances for a single lead longevity drug candidate function as a running signal to the wider industry, with each milestone renewing veterinary and media attention even though full commercial approval and launch remain a distinct, later step in the process.

KEY MARKET DRIVER

Rising Senior Pet Population and Insurance-Supported Preventive Care Are the Key Driver

• The UK's large and growing companion animal population is aging in line with improved veterinary care and nutrition over the pets' lifetimes, steadily expanding the base of senior dogs and cats that require structured geriatric support.
• Growing UK pet insurance penetration is giving owners greater financial capacity to pursue preventive and ongoing senior-pet care rather than deferring treatment until a condition becomes acute, directly supporting demand for recurring senior-pet care plans.
• Veterinary professional guidance increasingly emphasizes that proactive, structured care can materially improve quality of life for aging dogs and cats, reinforcing veterinary-level recommendation of senior-pet wellness programs over ad hoc, symptom-driven visits.
• Older pets frequently require repeated monitoring for pain, dental disease, and chronic conditions, and at-home services can help pets that find travel stressful or have mobility limitations, pattern UK pet longevity providers are increasingly building services around.

Key Market Opportunity

Expansion of Subscription-Based Geriatric Care Plans Creates Significant Market Opportunity

• Subscription-style senior-pet care plans that bundle wellness exams, diagnostics, and care navigation into a predictable recurring fee offer UK veterinary practices a way to build steadier, more forecastable revenue than episodic, symptom-driven visits alone.
• UK pet insurers that build preventive and early-intervention coverage specifically around senior-pet care could differentiate their offerings in a competitive market while supporting exactly the kind of proactive care this market is built around.
• Genetic and diagnostic testing providers that can connect breed- and age-related risk markers to structured care plans are positioned to become an integral upstream layer of the senior-pet care ecosystem rather than a standalone testing service.
• Major UK veterinary groups have been actively repositioning their brand identities during 2025 and 2026, creating a natural opportunity to introduce dedicated senior-pet and longevity service lines as part of these broader repositioning efforts.

United Kingdom Pet Longevity Market Size, 2025-2034 (USD Million)

Segmentation Analysis

Analysis by Service Type

Senior-Pet Care Plans held the largest market share in 2025, supported by the growing need for continuous and preventive healthcare among aging pets. Recurring wellness examinations, pain assessments, laboratory testing, dental monitoring, mobility planning, and ongoing health evaluations provide essential services that pet owners require regularly to manage age-related conditions, maintain quality of life, and identify potential health issues at an early stage.

Anti-Aging Drug Support Services are projected to grow at the fastest rate during the forecast period, supported by the advancement of canine longevity drug candidates through regulatory review and the resulting need for specialized veterinary services. These therapies are expected to create growing demand for patient screening, treatment eligibility assessment, owner counseling, ongoing health monitoring, and follow-up care, establishing a new service layer within veterinary longevity management.

Service Type categories include

• Senior-Pet Care Plans (Dominating Segment)
• Anti-Aging Drug Support Services (Highest Growth Segment)
• Veterinary Longevity Clinics
• Preventive Diagnostics & Genetic Screening
• Palliative & End-of-Life Care

Analysis by Pet Type

Senior Dogs held the largest market share in 2025, supported by the early focus of canine longevity drug development and geriatric mobility care on dogs. The segment benefits from a more established ecosystem of dog-focused veterinary services, diagnostic testing, mobility management, preventive health programs, and insurance-supported care. Growing awareness among owners about age-related health conditions and the importance of extending healthy lifespan is also encouraging greater use of regular screening and long-term care services for senior dogs.

Senior Cats are projected to grow at the fastest rate during the forecast period, driven by the increasing adoption of geriatric care protocols and diagnostic screening specifically tailored to aging cats. UK veterinary practices are expanding preventive health assessments, chronic-condition monitoring, dental evaluations, nutritional management, and mobility care for older cats, while greater owner awareness of feline aging is encouraging earlier and more frequent veterinary intervention. This expansion is helping address the historically underserved nature of structured senior-cat care and creating greater demand for specialized longevity-focused services.

Pet Type categories include

• Senior Dogs (Dominating Segment)
• Senior Cats (Highest Growth Segment)
• Large-Breed Dogs
• Chronic-Care Pets

Analysis by Customer Type

Pet Owners & Families held the largest market share in 2025, supported by the fact that senior-pet care is primarily funded and managed at the household level. Increasing pet humanization is encouraging owners to view aging pets as family members and prioritize their long-term health, comfort, and quality of life. This is driving greater spending on preventive veterinary visits, diagnostic screening, nutritional support, mobility management, and ongoing treatments for age-related conditions.

Pet Insurers are projected to grow at the fastest rate during the forecast period, supported by the increasing development of preventive and early-intervention coverage for senior pets in the UK. Insurers are gradually moving beyond a predominantly reactive claims-based approach by encouraging regular veterinary checkups, diagnostic screening, chronic-condition monitoring, and structured geriatric care plans. This shift toward proactive health management is expected to strengthen the role of pet insurance in supporting longer, healthier lives for aging animals.

Customer Type categories include

• Pet Owners & Families (Dominating Segment)
• Pet Insurers (Highest Growth Segment)
• Veterinary Clinics
• Mobile Vet Providers

Market Share

The United Kingdom Pet Longevity Market is fragmented and still emerging, with competition spanning large veterinary practice groups, pet insurers, animal-health companies, pet-care businesses, and independent veterinary providers. Major veterinary networks, including IVC Evidensia, CVS Group, Pets at Home, VetPartners, and Medivet and Partners, provide extensive access to preventive, diagnostic, specialist, and senior-pet care through their UK clinic and hospital networks, while independent practices such as FAB Vets and Etwall Vets complement these services with localized senior-pet and preventive-care programs. UK pet insurers, including Allianz Insurance (Petplan), Agria Pet Insurance, ManyPets, Waggel, and Vetsure, increasingly influence access to long-term and geriatric care through lifetime coverage and policy structures supporting treatment of age-related conditions. Global animal-health and pet-care companies, including Zoetis, Nestlé Purina PetCare, and Mars, contribute through veterinary pharmaceuticals, diagnostics, senior-focused nutrition, preventive health solutions, and pet-health research. Key success factors include building recurring relationships with pet owners, expanding preventive and senior-pet care offerings, integrating diagnostics and treatment into routine veterinary services, and providing credible clinical evidence and insurance coverage that support long-term health and healthy ageing.

Key Players

• IVC Evidensia (UK)
• CVS Group plc (UK)
• Pets at Home Group plc (UK)
• Allianz Insurance plc (Petplan) (UK)
• Agria Pet Insurance Ltd (UK)
• ManyPets Group Ltd (UK)
• Waggel Ltd (UK)
• Zoetis Inc. (US)
• Nestlé Purina PetCare (Switzerland)
• Mars, Incorporated (US)
• VetPartners Ltd (UK)
• Medivet and Partners (UK)
• Vetsure Pet Insurance Ltd (UK)
• FAB Vets (UK)
• Etwall Vets (UK)

Recent Market Developments

• June 2025: IVC Evidensia’s Pet Health Club partnered with Cats Protection to expand access to preventive veterinary care for cats in the UK. The initiative supports regular health checks and early intervention, contributing to improved long-term health and healthy ageing among companion animals.
• January 2026: IVC Evidensia’s Care Frameworks reached 100,000 animals, strengthening the standardization of evidence-based veterinary care across its UK network. The initiative supports earlier diagnosis and consistent treatment, contributing to improved long-term health and healthy ageing in companion animals.
• February 2026: IVC Evidensia launched its unified UK brand, “inspiring vet care,” across more than 900 veterinary practices. The expansion strengthens access to veterinary, preventive, and specialist services across the UK, supporting long-term pet health and healthy ageing.

Frequently Asked Questions

Key Questions Answered

Request a Sample

1

What is the United Kingdom Pet Longevity Market?

2

What is the CAGR of the United Kingdom Pet Longevity Market?

3

Which service type leads the United Kingdom Pet Longevity Market?

4

Which longevity intervention dominates the United Kingdom Pet Longevity Market?

5

Which pet type dominates the United Kingdom Pet Longevity Market?

6

What are the latest trends in the United Kingdom Pet Longevity Market?

7

Who are the key players in the United Kingdom Pet Longevity Market?

Why Choose IG Transformation

Speak to Analyst

Strong Industry Focus

Extensive Product Offerings

Customer Research Services

Robust Research Methodology

Comprehensive Reports

Latest Technological Developments

Value Chain Analysis

Potential Market Opportunities

Growth Dynamics

Quality Assurance

Post-sales Support

Regular Report Updates